Changyan Zou
Overview
Explore the profile of Changyan Zou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang S, Zou C, Lin X, Hu D, Su Y, He H, et al.
Sci Rep
. 2023 May;
13(1):7523.
PMID: 37160927
Gastric cancer (GC) is one of the major causes of cancer deaths with 5-year survival ratio of 20%. RNU12 is one of long noncoding RNAs (lncRNAs) regulating the tumor progression....
2.
He H, Lin K, Zou C, Pan J, Fu W, Zhou Y, et al.
Front Oncol
. 2022 Apr;
12:769544.
PMID: 35371986
Annexin A2 (ANXA2) has been found to be involved in cancer proliferation, metastasis and prognosis; however, its exact role in nasopharyngeal carcinoma (NPC) radioresistance remains unknown. We found that ANXA2...
3.
Zou C, Liao J, Hu D, Su Y, Lin H, Lin K, et al.
Front Oncol
. 2021 Nov;
11:734694.
PMID: 34722282
SNHG8, a family member of small nucleolar RNA host genes (SNHG), has been reported to act as an oncogene in gastric carcinoma (GC). However, its biological function in Epstein-Barr virus...
4.
Liao J, Chen Z, Yu Z, Huang T, Hu D, Su Y, et al.
Front Oncol
. 2020 Nov;
10:585292.
PMID: 33194732
Cancer patients who initially benefit from Erlotinib, a drug targeting path, eventually develop resistance to the drug. The underlying mechanism is largely unknown. This study investigated the role of in...
5.
He H, Qie S, Guo Q, Chen S, Zou C, Lu T, et al.
Cancer Manag Res
. 2019 Aug;
11:6411-6424.
PMID: 31372045
Stanniocalcin 2 (STC2) expression is upregulated under multiple stress conditions including hypoxia, nutrient starvation and radiation. Overexpression of STC2 correlates with tumor progression and poor prognosis. We previously demonstrated that...
6.
Chen Y, Chen Z, Su Y, Lin D, Chen M, Feng S, et al.
Cancer Cell Int
. 2019 Mar;
19:37.
PMID: 30820190
Background: The staging system of nasopharyngeal carcinoma (NPC) has close relationship with the degree of cell differentiation, but most NPC patients remain undiagnosed until advanced phases. Novel metabolic markers need...
7.
He H, Lin K, Su Y, Lin S, Zou C, Pan J, et al.
Cell Physiol Biochem
. 2018 Nov;
50(5):1929-1944.
PMID: 30396174
Background/aims: Nasopharyngeal carcinoma (NPC) is rare worldwide but remains highly prevalent in endemic regions, notably in southern China. Radiotherapy remains the treatment of choice for NPC, but radioresistance has been...
8.
Liao J, Lin J, Lin D, Zou C, Kurata J, Lin R, et al.
Sci Rep
. 2017 Apr;
7(1):781.
PMID: 28396596
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are standard treatments for advanced non-small-cell lung cancer (NSCLC) patients. However, acquired resistance to EGFR-TKIs is widely detected across the world,...
9.
Qiu S, Li C, Lin J, Xu Y, Lu J, Huang Q, et al.
J Biomed Opt
. 2016 Dec;
21(12):125003.
PMID: 27936269
Surface-enhanced Raman spectroscopy (SERS) was employed to detect deoxyribose nucleic acid (DNA) variations associated with the development of nasopharyngeal carcinoma (NPC). Significant SERS spectral differences between the DNA extracted from...
10.
Ou L, Chen Y, Su Y, Zou C, Chen Z
Appl Spectrosc
. 2016 Oct;
70(11):1821-1830.
PMID: 27703049
Structural changes and chemical modifications in DNA during interactions with X-ray radiation are still not clear within 48 h of incubation. We investigate genomic DNA from the radiated CNE2 cell...